Publication | Open Access

A chemical biology approach identifies a beta-2 adrenergic receptor agonist that causes human tumor regression by blocking the Raf-1/Mek-1/Erk1/2 pathway

Molecular PharmacologyTumor BiologyMedicineReceptor Tyrosine KinaseChemical Biology ApproachReceptor (Biochemistry)Raf-1/mek-1/erk1/2 PathwayPharmacologyRadiation OncologyCell SignalingHuman Tumor RegressionCancer ResearchEndocrine-related Cancer